IP Library Granted Patent US 10,441,621
Granted Patent B2
US 10,441,621 · App. 15/396,201 · Granted Oct 15, 2019

Flavonoid compositions and methods of use

Inventor: Kurt Richards (Herriman, UT)
Assignee: REOXCYN, LLC
A61K36/82A61K9/0056A61K31/202A61K31/341A61K31/352A61K31/353A61K31/522A61K36/45
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,441,621
App. No.
15/396,201
Granted
Oct 15, 2019
Kind
B2
Abstract

Flavonoid compositions containing the flavonoid quercetin and/or derivatives of quercetin are disclosed. The flavonoid compositions are formulated to improve the bioavailability of quercetin. Also provided herein are methods for improving athletic performance, improving cardiovascular health, and aiding in immune response and methods of improving athletic performance, improving bone health, preventing fatigue, reducing recovery time after exercise, countering oxidative stress, and/or boosting energy.

Claims (20)

1. A method of increasing gut-derived phenolics in a subject, comprising:

administering a composition comprising bilberry fruit extract, green tea leaf extract, quercetin present in an amount of about 7.9% to about 16% (w/w), and omega 3 fatty acids to the subject.

2. The method of claim 1 , wherein the increased gut-derived phenolics are one or more of 1,2,3-benzenetriol sulfate, 3-methoxycatechol sulfate, 3-(3-hydroxyphenyl)propanoic acid sulfate, 3-hydroxyhippurate, or 4-methylcatechol sulfate.

3. The method of claim 1 , wherein the composition further comprises caffeine and vitamin C.

4. The method of claim 1 , wherein the omega 3 fatty acids comprises docosahexaenoic acid and eicosapentaenoic acid.

5. The method of claim 1 , wherein the composition further comprises a bioavailability enhancing agent selected from the group consisting of a solubilizing compound, a reducing compound, a stabilizing compound, a lubricating compound, an enteric coating, and a permeability enhancing compound.

6. The method of claim 1 , wherein the bilberry extract is present in an amount of 10-500 mg, the green tea leaf extract is present in an amount of 10-500 mg, the quercetin is present in an amount of 10-500 mg, and the omega 3 fatty acids is present in an amount of 10-500 mg.

7. The method of claim 1 , wherein the bilberry fruit extract comprises about 25% total anthocyanins.

8. The method of claim 1 , wherein the green tea leaf extract comprises about 50% epigallocatechin 3-gallate (EGCG).

9. The method of claim 2 , wherein the increased gut-derived phenolic 3-methoxycatechol sulfate is increased between 1-fold and 2 fold.

10. The method of claim 2 , wherein the increased gut-derived phenolic 3-(3-hydroxyphenyl)propanoic acid sulfate is increased between 0.5-fold and 1 fold.

11. The method of claim 2 , wherein the increased gut-derived 1,2,3-benzenetriol sulfate is increased between 1-fold and 2 fold.

12. The method of claim 1 , wherein the composition is administered to a subject at a dose of two tablets twice daily.

13. The method of claim 1 , wherein the composition is administered to a subject two to four times each day.

14. The method of claim 1 , wherein the gut-derived phenolics are gut-derived phenolic metabolites.

15. The method of claim 3 , wherein caffeine is present in an amount of 10-500 mg.

16. The method of claim 3 , wherein the vitamin C is present in an amount of 10-500 mg.

17. The method of claim 1 , wherein the composition further comprises one or more sugar, natural and artificial flavors, cellulose gum, sucralose, bamboo whole plant extract, guar gum, xanthan gum, citric acid, malic acid, or L-tartaric acid.

18. The method of claim 1 , wherein the composition is formulated as a chewable tablet.

19. The method of claim 1 , wherein the composition is administered to a subject prior to a meal.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2020
From: REOXCYN, LLC
To: BERKLEY, LLC
Reel/Frame 054021/0697 →
CHANGE OF NAME Recorded Jul 24, 2018
From: REOXCYN INNOVATION GROUP, LLC
To: REOXCYN, LLC.
Reel/Frame 046620/0800 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: REOXCYN DISCOVERIES GROUP, INC.
To: REOXCYN INNOVATION GROUP, LLC
Reel/Frame 044783/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2017
From: RICHARDS, KURT
To: REOXCYN DISCOVERIES GROUP, INC.
Reel/Frame 042439/0745 →
Continuity (3)
Continuation In Part 15272826 · Sep 22, 2016
Provisional Application 62222667 · Sep 23, 2015
Related Publication 20170106036A1 · Apr 20, 2017
Cited By (1)
US 12,274,730